6-KEvogene Ltd. entered into a Sales Agreement to conduct an "at the market offering" of its ordinary shares for an aggregate offering price of up to $2,926,500. This offering allows the company to sell shares through an agent on the Nasdaq Stock Market or other permitted methods.